Skip to content

Healthcare Professional

Medigus' SRS is a cutting edge disposable endoscope providing you with the most simple and effective treatment for GERD symptoms in lieu of a laparoscopic surgery.

The SRS flexible endoscope combines a miniaturized video camera, a surgical stapler and ultrasonic sights for alignment - all in a single instrument. The SRS is designed to allow you to perform a true anterior fundoplication endoluminally, thereby revolutionizing the treatment of GERD without the need for open or laparoscopic surgery.

The procedure is remarkably simple, swift and with excellent results - best ever reported for any endoluminal treatment for GERD.

The SRS™ endoscopy system is CE marked and FDA cleared.

Please contact us for further information.

SRS SYSTEM

Leading the GERD Revolution

Medigus has designed and created an entire endoscopic system for intra-luminal treatment of Gastroesophageal Reflux Disease (GERD).

Medigus' SRS™ innovative endoscopy system for the treatment of GERD performs an anterior fundoplication in lieu of the current sugical procedure, but without opening the abdominal cavity. The SRS™ endoscopy system is CE marked and FDA cleared.

SRS SYSTEM - See how it works

GERD has a tremendous adverse impact on a person's quality of life and has additional associated risk.s, including esophageal cancer.

FAQS

The SRS solution for GERD is functionally identical to a standard laparoscopic surgical procedure (anterior fundoplication). It restores a normal gastro-esophageal flap valve. Consequently, the available clinical results to date compare favorably with the results of laparoscopic surgery.

Subcategories

Publications
Welcome to Medigus publications archive. Selected relevant clinical academic publications are presented here.

Medigus is a medical device company specializing in developing innovative endoscopic procedures and devices, including the revolutionary disposable endoscope for the treatment of GERD (Gastroesophageal Reflux Disease).

The company, which was founded in January 2000, is based in Israel and is publicly traded on the TASE. Medigus owns a unique and outstanding technological platform enabling the company to bring into the world state-of-the-art medical device products.

Read more

News

1
2
3
4
5
6
7
8
9
10

Prev Next

Successful Three-Year Follow-Up Data of the SRS™ Pivotal Study in Indiana University Will be Presented at the Digestive Disease Week in Orlando

16-05-2013

Medigus Ltd. (MDGS.TA), a leading medical device company dedicated to the development of innovative endoscopic procedures and technologies, will be presenting the successful three year follow-up da...

DDW Digestive Disease Week

06-05-2013

May 18-21, 2013
Orlando, Florida

Visit us at booth #1721

Successful five-year follow-up data from SRS™ pilot study

05-05-2013

Medigus (TASE:MDGS) announced today that it had received five-year follow-up results of a pilot study of its SRS™ endoscopic system for the treatment of Gastroesophageal Reflux Disease (GERD). The ...

EAES European Association for Endoscopic Surgery

19-04-2013

June 19-22, 2013
Vienna, Austria
Visit us at booth #25

SAGES Society of American Gastrointestinal and Endoscopic Surgeons

10-04-2013

April 17-20, 2013
Baltimore, Maryland

http://www.sages2013.org/
Read more

Medigus Signed a Distribution Agreement in China

12-03-2013

Local distributor to purchase SRS™II systems for a minimum of $3.85 million.

Medigus completed $8M private placement by OrbiMed

04-03-2013

Medigus (TASE:MDGS) announces that it had closed an $8 million investment by OrbiMed Israel Partners LP. Upon the closing of the investment, Dr. Nissim Darvish, senior managing director at OrbiMed ...

AGA Tech Summit: Fostering Innovation and Technology in Digestive and Metabolic Diseases

14-02-2013

March 15-16, 2013
East Palo Alto, California

http://www.gast...

Columbia Medical Center Offers SRS Procedures

13-02-2013

Medigus (TASE:MDGS) announces that Columbia University Medical Center, Department of Surgery (New-York, New-York), now offers the SRS™ procedure for transoral incisionless treatment of GERD.